about
Heterogeneity of Diffusion-Weighted Imaging in Tumours and the Surrounding Stroma for Prediction of Ki-67 Proliferation Status in Breast CancerPrognostic value of Ki67 index in gastrointestinal stromal tumors.Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC)Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy.Vasohibin‑2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor‑2 and growth/differentiation factor‑15 expressionParameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients.Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based studyThe correlation between Ki-67 with other prognostic factors in breast cancer: A study in Iranian patients.Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registryPrognostically Distinctive Subgroup in Pathologic N3 Breast Cancer.Ki-67 is a prognostic marker for hormone receptor positive tumors.MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer.Immunohistochemical Markers as Predictors of Histopathologic Response and Prognosis in Rectal Cancer Treated with Preoperative Adjuvant Therapy: State of the Art.Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancer.Phosphorylated ribosomal S6 (p-rpS6) as a post-treatment indicator of HER2 signalling targeted drug resistance.A high-resolution transcriptome map of cell cycle reveals novel connections between periodic genes and cancer.Prognostic value of tissue-based biomarker signature in clear cell renal cell carcinoma.Reproducibility and Prognostic Potential of Ki-67 Proliferation Index when Comparing Digital-Image Analysis with Standard Semi-Quantitative Evaluation in Breast Cancer.Correlation between the Expression of Topo IIα and Ki67 in breast cancer and its clinical Pathological characteristics.MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.Expression of vascular endothelial growth factor and caspase-3 in mucinous breast carcinoma and infiltrating ductal carcinoma-not otherwise specified, and the correlation with disease-free survival.Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors.Prognostic genes of breast cancer revealed by gene co-expression network analysis.Phyllodes tumors of the breast in 2 sisters: Case report and review of literature.Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer.DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes.Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis.Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluationPrognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis
P2860
Q33767081-B6E8D048-2FBC-4474-BA5D-D1A457A0C309Q33802994-49B85496-810E-4ADD-B060-72B19D7059D7Q33856467-577986FA-DEC2-46E2-B65D-AD3A13111DDCQ33879820-71E9E59A-4F2A-4C85-9A45-DE84EDD3C70CQ33891210-8765E012-F99E-42D9-94B0-F0AC0CBFFCE9Q35073311-45061CDC-5C68-406B-AB70-C1A47962A285Q35866408-E5E1C039-F7DE-40B1-8902-55C764B0E49BQ35944405-8F94ECEE-E3E2-4300-B61F-593683481777Q36861451-02833BC4-E88F-4CC9-B41E-BFDB45F30F90Q36892788-3A9DA2C0-16B8-4773-9A2F-3301D59E2260Q37056923-879B9969-AD0D-424F-98D9-7E1EBBC5D4C8Q37245861-A4EE5829-A632-48E9-AD1F-5224A2E710C0Q37625750-53DC6C2E-2DB1-420E-829A-82B3382800E6Q37641757-C88DA5D2-AFCA-441A-8DD5-2A25E3E448DCQ37689910-E380F94F-689E-4F28-9948-739BB6FD6F8FQ37699132-0042020B-134E-46F3-9329-2F97B73E5B32Q38838851-C15E0AB4-6F3C-4D9B-90FC-F116DA873BB1Q39641111-9EE0566B-CE53-4C01-A673-50298C0F1CBBQ40386057-04CF9FB0-41FA-4975-975A-A8EEDC401DAEQ40460628-19CB747B-05D1-4416-932D-4E2307206EEFQ42669663-4DE9B146-337C-4C03-9579-CEAA0E6BEBB2Q43184280-7EE39F88-C94A-412B-AC73-4FF914317240Q45736517-37088506-B3D6-4C5B-98AF-87A613B0F31EQ46581912-6F61F692-D73A-4B77-8C2F-29B7E9B236B2Q47095948-7965D5E2-D18D-4BAC-833D-F9AB3DF9DF61Q47165206-107ABFCA-3012-4185-8807-1566FAA5F523Q48270057-91AF07C0-66B1-41F4-9F6B-816005E74108Q51734273-1E5934FE-4287-468F-AB4C-183D0924907EQ55286708-9E4D8EB6-8D49-466A-B8BB-BEEDB5D2606CQ58726869-89DB61DC-0FB4-482F-8E5C-A0DB1D957393Q58750368-F6C0F815-0804-4E16-ACB0-85D871973C0A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Correlation between Ki67 and breast cancer prognosis.
@en
type
label
Correlation between Ki67 and breast cancer prognosis.
@en
prefLabel
Correlation between Ki67 and breast cancer prognosis.
@en
P2093
P2860
P356
P1433
P1476
Correlation between Ki67 and breast cancer prognosis.
@en
P2093
George Karaolanis
Ioannis Alexiou
Ioannis Karaiskos
Ioannis Pateras
Konstantinos Konstantoudakis
Konstantinos Kontzoglou
Michael Stamatakos
Victoria Palla
P2860
P304
P356
10.1159/000346475
P577
2013-01-24T00:00:00Z